Prognostic significance of perioperative chemotherapy on resectable colorectal mucinous adenocarcinoma liver metastasis | Zendy

Cong Li | Zendy; Dongfang Su | Zendy; Jianhong Peng | Zendy; Yujing Fang | Zendy; Wenhao Zhou | Zendy; Shaohua Li | Zendy; Baojia Luo | Zendy; Desen Wan | Zendy; Zhizhong Pan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognostic significance of perioperative chemotherapy on resectable colorectal mucinous adenocarcinoma liver metastasis

Author(s) -

Cong Li,

Dongfang Su,

Jianhong Peng,

Yujing Fang,

Wenhao Zhou,

Shaohua Li,

Baojia Luo,

Desen Wan,

Zhizhong Pan

Publication year - 2019

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 19

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm.2019.09.16

Subject(s) - medicine , chemotherapy , colorectal cancer , perioperative , adenocarcinoma , general surgery , metastasis , oncology , distant metastasis , radiology , cancer

Mucinous adenocarcinoma (MAC) is an uncommon subtype of colorectal cancer (CRC). For colorectal cancer liver metastasis (CRLM), perioperative chemotherapy (PCT) has been developed to improve the rate of resection and reduce the rate of early recurrence; however, its impact on long-term outcomes in MAC is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research